Vicarious Surgical shares rise 20.77% intraday after reducing 2025 cash burn guidance to $45M from $50M.

Vicarious Surgical surged 20.77% intraday after announcing a $5 million reduction in its 2025 cash burn guidance to $45 million, driven by disciplined cost management initiatives. The company attributed the improvement to operational efficiency measures and a leaner cost structure, aligning with its long-term strategy. Concurrently, board restructuring—including new committee appointments—reinforced governance adjustments amid the operational reset. These developments, emphasizing financial prudence and strategic realignment, likely spurred investor optimism, offsetting prior concerns over cash burn and weak stock performance.